ATE262926T1 - Asorbierbare mikropartikel - Google Patents
Asorbierbare mikropartikelInfo
- Publication number
- ATE262926T1 ATE262926T1 AT99903216T AT99903216T ATE262926T1 AT E262926 T1 ATE262926 T1 AT E262926T1 AT 99903216 T AT99903216 T AT 99903216T AT 99903216 T AT99903216 T AT 99903216T AT E262926 T1 ATE262926 T1 AT E262926T1
- Authority
- AT
- Austria
- Prior art keywords
- asorbable
- microparticles
- asorbable microparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1539498A | 1998-01-29 | 1998-01-29 | |
| PCT/US1999/001180 WO1999038536A1 (en) | 1998-01-29 | 1999-01-20 | Absorbable microparticles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE262926T1 true ATE262926T1 (de) | 2004-04-15 |
Family
ID=21771154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99903216T ATE262926T1 (de) | 1998-01-29 | 1999-01-20 | Asorbierbare mikropartikel |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060210641A1 (de) |
| EP (1) | EP1053020B1 (de) |
| JP (2) | JP3842042B2 (de) |
| CN (1) | CN1289256A (de) |
| AR (1) | AR014510A1 (de) |
| AT (1) | ATE262926T1 (de) |
| AU (1) | AU2329199A (de) |
| CA (1) | CA2318152A1 (de) |
| DE (1) | DE69916031T2 (de) |
| DK (1) | DK1053020T3 (de) |
| ES (1) | ES2217738T3 (de) |
| HU (1) | HUP0101250A3 (de) |
| IL (2) | IL137388A (de) |
| NO (1) | NO20003810L (de) |
| PL (1) | PL193111B1 (de) |
| PT (1) | PT1053020E (de) |
| RU (1) | RU2237471C2 (de) |
| TW (1) | TWI255721B (de) |
| WO (1) | WO1999038536A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413539B1 (en) * | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| AU2002214942A1 (en) * | 2000-11-16 | 2002-05-27 | Novo-Nordisk A/S | Analogues and derivatives of gastrin releasing peptide (grp) |
| FR2825273B1 (fr) * | 2001-05-29 | 2006-11-24 | Oreal | Composition pour le traitement des signes cutanes du vieillissement |
| JP2007536214A (ja) | 2003-12-16 | 2007-12-13 | ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス | Ｇｌｐ−１類似体 |
| EP1703916A2 (de) * | 2004-01-13 | 2006-09-27 | Vasogenix Pharmaceuticals, Inc. | Verfahren zur behandlung eines akuten myokardinfarkts mit einem mit dem calicitonin-gen in verbindung stehenden peptid sowie dieses enthaltende zusammensetzungen |
| US7976847B2 (en) | 2004-01-13 | 2011-07-12 | Vasogenix Pharmaceuticals, Inc. | Controlled release CGRP delivery composition for cardiovascular and renal indications |
| DK2118123T3 (en) | 2007-01-31 | 2016-01-25 | Dana Farber Cancer Inst Inc | Stabilized p53 peptides and uses thereof |
| US8592377B2 (en) | 2007-03-28 | 2013-11-26 | President And Fellows Of Harvard College | Stitched polypeptides |
| EP2200626A4 (de) | 2007-09-07 | 2012-02-15 | Ipsen Pharma Sas | Analoga von exendin-4 und exendin-3 |
| RU2509809C2 (ru) | 2008-07-04 | 2014-03-20 | Транслэшионал Кэнсэр Драгз Фарма, С.Л. | Способы лечения и диагностики рака |
| AU2009280021B2 (en) | 2008-08-07 | 2012-10-04 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal |
| WO2010016940A2 (en) | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide |
| KR20110043687A (ko) | 2008-08-07 | 2011-04-27 | 입센 파마 에스.에이.에스 | 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 절단형 유사체 |
| JP2012517459A (ja) | 2009-02-12 | 2012-08-02 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ | 代謝障害治療のためのカルジオトロフィン１の使用 |
| WO2011011072A2 (en) | 2009-07-22 | 2011-01-27 | Ipsen Pharma S.A.S. | Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59 |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| EP2603520A4 (de) * | 2010-08-10 | 2014-02-19 | Ecole Polytech | Erythrozytenbindende therapeutika |
| ES2711526T3 (es) | 2010-08-13 | 2019-05-06 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
| EA018472B1 (ru) * | 2010-09-15 | 2013-08-30 | Открытое Акционерное Общество "Протек" | Частицы, содержащие эритропоэтин, для лечения и профилактики неврологических и гематологических заболеваний и нарушений |
| BR112013027222B1 (pt) * | 2011-06-14 | 2022-07-12 | Ipsen Pharma S.A.S. | Composição de liberação sustentada que contém peptídeos como ingrediente ativo |
| TW201806968A (zh) | 2011-10-18 | 2018-03-01 | 艾利倫治療公司 | 擬肽巨環化合物 |
| ES2985784T3 (es) | 2011-11-18 | 2024-11-07 | Regeneron Pharma | Micropartículas de proteínas recubiertas con polímeros para formulaciones de liberación prolongada para su uso en el humor vítreo del ojo para tratar trastornos oculares vasculares |
| BR112014020103A2 (pt) | 2012-02-15 | 2018-10-09 | Aileron Therapeutics, Inc. | macrociclos peptidomiméticos |
| EP2819688A4 (de) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | Triazol- und thioethervernetzte peptidomimetische makrozyklen |
| WO2014071241A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| SG11201606761RA (en) | 2014-02-21 | 2016-09-29 | Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| EP3197478A4 (de) | 2014-09-24 | 2018-05-30 | Aileron Therapeutics, Inc. | Peptidomimetische makrozyklen und verwendungen davon |
| WO2016154058A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CA3004363A1 (en) | 2015-11-06 | 2017-05-11 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same |
| WO2018232176A1 (en) | 2017-06-16 | 2018-12-20 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EP3790577A4 (de) | 2018-05-09 | 2022-04-27 | The University of Chicago | Zusammensetzungen und verfahren im zusammenhang mit immuntoleranz |
| CN113281317B (zh) * | 2021-05-14 | 2022-04-29 | 北京指真生物科技有限公司 | 一种含有花菁类化合物的编码微球及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| US5011692A (en) * | 1985-12-28 | 1991-04-30 | Sumitomo Pharmaceuticals Company, Limited | Sustained pulsewise release pharmaceutical preparation |
| US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5077049A (en) * | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| AU653771B2 (en) * | 1991-01-03 | 1994-10-13 | Alkermes Controlled Therapeutics, Inc. | Stabilization of proteins by cationic biopolymers |
| RU2113220C1 (ru) * | 1991-07-24 | 1998-06-20 | Энзакор Пропертиз Лимитед | Композиция, способ лечения кишечной инфекции, способ неспецифической стимуляции имvунной системы, способ доставки биологически активного материала в верхние отделы тонкого кишечника |
| US5366756A (en) * | 1992-06-15 | 1994-11-22 | United States Surgical Corporation | Method for treating bioabsorbable implant material |
| US5672659A (en) * | 1993-01-06 | 1997-09-30 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| EP0626170A3 (de) * | 1993-05-10 | 1996-03-27 | Sandoz Ltd | Stabilisierung pharmakologisch aktiver Verbindungen in Mitteln mit verzögerter Freisetzung. |
| CA2167920A1 (en) * | 1993-07-23 | 1995-02-02 | Abraham J. Domb | Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5612052A (en) * | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US5795922A (en) * | 1995-06-06 | 1998-08-18 | Clemson University | Bone cement composistion containing microencapsulated radiopacifier and method of making same |
| US5665702A (en) * | 1995-06-06 | 1997-09-09 | Biomeasure Incorporated | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| KR100210509B1 (ko) * | 1996-01-10 | 1999-07-15 | 성재갑 | 지속성 동물 성장 호르몬 제형 및 이의 제조 방법 |
-
1999
- 1999-01-20 DE DE69916031T patent/DE69916031T2/de not_active Expired - Fee Related
- 1999-01-20 PT PT99903216T patent/PT1053020E/pt unknown
- 1999-01-20 ES ES99903216T patent/ES2217738T3/es not_active Expired - Lifetime
- 1999-01-20 EP EP99903216A patent/EP1053020B1/de not_active Expired - Lifetime
- 1999-01-20 JP JP2000529268A patent/JP3842042B2/ja not_active Expired - Fee Related
- 1999-01-20 CN CN99802517A patent/CN1289256A/zh active Pending
- 1999-01-20 RU RU2000122622A patent/RU2237471C2/ru not_active IP Right Cessation
- 1999-01-20 AT AT99903216T patent/ATE262926T1/de not_active IP Right Cessation
- 1999-01-20 PL PL342662A patent/PL193111B1/pl not_active IP Right Cessation
- 1999-01-20 IL IL13738899A patent/IL137388A/xx unknown
- 1999-01-20 AU AU23291/99A patent/AU2329199A/en not_active Abandoned
- 1999-01-20 DK DK99903216T patent/DK1053020T3/da active
- 1999-01-20 HU HU0101250A patent/HUP0101250A3/hu unknown
- 1999-01-20 WO PCT/US1999/001180 patent/WO1999038536A1/en not_active Ceased
- 1999-01-20 CA CA002318152A patent/CA2318152A1/en not_active Abandoned
- 1999-01-28 TW TW088101329A patent/TWI255721B/zh not_active IP Right Cessation
- 1999-01-28 AR ARP990100340A patent/AR014510A1/es not_active Application Discontinuation
-
2000
- 2000-01-20 IL IL13738800A patent/IL137388A0/xx unknown
- 2000-07-25 NO NO20003810A patent/NO20003810L/no unknown
-
2004
- 2004-09-13 JP JP2004265825A patent/JP2005047928A/ja active Pending
-
2006
- 2006-03-20 US US11/385,030 patent/US20060210641A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101250A3 (en) | 2006-06-28 |
| IL137388A0 (en) | 2001-07-24 |
| EP1053020B1 (de) | 2004-03-31 |
| DK1053020T3 (da) | 2004-07-26 |
| TWI255721B (en) | 2006-06-01 |
| AU2329199A (en) | 1999-08-16 |
| JP3842042B2 (ja) | 2006-11-08 |
| NO20003810L (no) | 2000-09-13 |
| DE69916031D1 (de) | 2004-05-06 |
| ES2217738T3 (es) | 2004-11-01 |
| CN1289256A (zh) | 2001-03-28 |
| PL193111B1 (pl) | 2007-01-31 |
| US20060210641A1 (en) | 2006-09-21 |
| EP1053020A1 (de) | 2000-11-22 |
| NO20003810D0 (no) | 2000-07-25 |
| JP2002501908A (ja) | 2002-01-22 |
| IL137388A (en) | 2005-05-17 |
| DE69916031T2 (de) | 2005-02-17 |
| WO1999038536A1 (en) | 1999-08-05 |
| AR014510A1 (es) | 2001-02-28 |
| PT1053020E (pt) | 2004-06-30 |
| HUP0101250A2 (hu) | 2001-08-28 |
| RU2237471C2 (ru) | 2004-10-10 |
| PL342662A1 (en) | 2001-07-02 |
| JP2005047928A (ja) | 2005-02-24 |
| CA2318152A1 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69916031D1 (de) | Asorbierbare mikropartikel | |
| NO984808D0 (no) | Mikropartikler | |
| DE69926979D1 (de) | Leitschaufelbefestigung | |
| ID29066A (id) | Turunan fenilglisina | |
| ID27423A (id) | Turunan kuinolin | |
| DE69904595D1 (de) | Betacarbolinverbindungen | |
| DE69909757D1 (de) | Ethylencopolymerisationsverfahren | |
| DE59902874D1 (de) | Buchsenkontakt | |
| ID23234A (id) | Turunan-turunan benzosulfona | |
| ID27484A (id) | Turunan adenosina | |
| DE69933073D1 (de) | Informationsaufzeichnungsträgercassette | |
| FI20002715L (fi) | Kaiuttimet | |
| DE69928148D1 (de) | Wasserskimmer | |
| DE59907306D1 (de) | Fadenchangierung | |
| ID27547A (id) | Turunan kuinolin | |
| DE69937642D1 (de) | Trimaranstruktur | |
| DE69902880D1 (de) | Resonanzumwandlerschaltung | |
| DE69907576D1 (de) | Solenoidantriebsvorrichtung | |
| DE69918125D1 (de) | Formschliessvorrichtung | |
| DE69930626D1 (de) | Sorptionsreinigungstuch | |
| DE59913393D1 (de) | Fadenchangierung | |
| DE69827358D1 (de) | Weglenkungsverfahren | |
| DE69938476D1 (de) | Münzschiebespielgerät | |
| DE59808995D1 (de) | Endomikroskopsystem | |
| ID28356A (id) | Turunam tiazola |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1053020 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |